Objectives The aim of this study is to explore the effectiveness and safety of high dose
dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to SARS-Cov …

The aim of this study was to evaluate the clinical effects of dexamethasone administration in
patients with mild to moderate acute respiratory distress syndrome (ARDS) due to …

Background: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage.
Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce …

Objective In this study, we aimed to compare the effects of intravenous dexamethasone and
methylprednisolone on the treatment of inpatients with COVID-19. Methods In this …

ABSTRACT BACKGROUND: Dexamethasone, a synthetic glucocorticoid, has anti-
inflammatory and immunosuppressive properties. There is a hyperinflammatory response …

The WHO announced coronavirus disease 2019 (COVID-19) as a pandemic disease
globally on March 11, 2020, after it emerged in China. The emergence of COVID-19 has …

Recent announcements indicated, without sharing any distinct published set of results, that
use of the corticosteroid dexamethasone in a large trial in the UK apparently reduced …

Dexamethasone implementation for COVID-19 management represented a milestone but
data regarding its impact and safety have not been consistently reproduced. We aimed to …

Dexamethasone can reduce mortality in hospitalised COVID-19 patients needing oxygen
and ventilation by 18% and 36%, respectively. Here, we estimate the potential number of …

After reading around regarding the state of knowledge surrounding the COVID-19 outbreak,
we were intrigued by the lack of a general consensus on what constituted effective anti-viral …